-
[show abstract]
[hide abstract]
ABSTRACT: Veränderungen im Alternsprozess des Mannes ähneln Veränderungen bei jüngeren, hypogonadalen Männern. Obgleich der Testosteronspiegel
im Mittel mit dem Lebensalter abfällt, sind Korrelationen zwischen Beschwerden im mittleren und höheren Lebensalter und Testosteronspiegel
inkonsistent und gering. Dies hängt u. a. mit methodischen Beschränkungen vorliegender Studien, der hohen Variabilität der
Testosteronwerte im Alter, unklaren Referenzwerten für ältere Männer und vielfältigen Einflüssen (Gesundheitszustand und -verhalten)
auf Testosteronwerte zusammen.
Bei der Untersuchung des Zusammenhangs zwischen Testosterondefizit und Altersbeschwerden sind eine Reihe psychosozialer Einflussfaktoren
(Wahrnehmung, Bewertung und Bewältigung altersbedingter Veränderungen etc.) zu berücksichtigen.
Age-related changes in men resemble symptoms of hypogonadism. Although the average levels of testosterone decrease with age,
correlations between complaints and testosterone levels are inconsistent and low in aging men. This is related to methodological
limitations of studies, the high interindividual variability of testosterone in the aging male, ambiguities of normal values,
and numerous determinants (e. g., health status, health behavior) on the level of testosterone.
When studying the relationship between decreased testosterone, psychological and physical complaints have to take into consideration
a whole array of psychosocial influences (e. g., perception, interpretation, and coping with age-related changes).
Der Urologe 04/2012; 39(5):414-417. · 0.50 Impact Factor
-
Psychotherapeut 01/2011; 56(5):369-370. · 0.36 Impact Factor
-
F. Leichsenring,
S. Salzer, M. Beutel,
K. von Consbruch,
S. Herpertz,
W. Hiller,
J. Hoyer,
J. Hüsing,
E. Irle,
P. Joraschky, [......],
M. Ruhleder,
H. Schauenburg,
U. Stangier,
B. Strauß,
C. Subic-Wrana,
S. Vormfelde,
G. Weniger,
U. Willutzki,
J. Wiltink,
E. Leibing
Psychotherapie, Psychosomatik, Medizinische Psychologie. 01/2009; 59:117-123.
-
F Leichsenring,
J Hoyer, M Beutel,
S Herpertz,
W Hiller,
E Irle,
P Joraschky,
H H Konig,
T M de Liz,
B Nolting, [......],
S Salzer,
H Schauenburg,
U Stangier,
B Strauss,
C Subic-Wrana,
S Vormfelde,
G Weniger,
U Willutzki,
J Wiltink,
E Leibing
[show abstract]
[hide abstract]
ABSTRACT: This paper presents the Social Phobia Psychotherapy Research Network. The research program encompasses a coordinated group of studies adopting a standard protocol and an agreed-on set of standardized measures for the assessment and treatment of social phobia (SP). In the central project (study A), a multicenter randomized controlled trial, refined models of manualized cognitive-behavioral therapy and manualized short-term psychodynamic psychotherapy are compared in the treatment of SP. A sample of 512 outpatients will be randomized to either cognitive-behavioral therapy, short-term psychodynamic psychotherapy or waiting list. Assessments will be made at baseline, at the end of treatment and 6 and 12 months after the end of treatment. For quality assurance and treatment integrity, a specific project using highly elaborated measures has been established (project Q). Study A is complemented by 4 interrelated add-on projects focusing on attachment style (study B1), on cost-effectiveness (study B2), on variation in the serotonin transporter gene in SP (study C1) and on structural and functional deviations of the hippocampus and amygdala (study C2). Thus, the Social Phobia Psychotherapy Research Network program enables a highly interdisciplinary research into SP. The unique sample size achieved by the multicenter approach allows for studies of subgroups (e.g. comorbid disorders, isolated vs. generalized SP), of responders and nonresponders of each treatment approach, for generalization of results and for a sufficient power to detect differences between treatments. Psychological and biological parameters will be related to treatment outcome, and variables for differential treatment indication will be gained. Thus, the results provided by the network may have an important impact on the treatment of SP and on the development of treatment guidelines for SP.
Psychotherapy and Psychosomatics 11/2008; 78(1):35-41. · 6.28 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The objective of this study was to validate the German version of the Vertigo Symptom Scale (VSS) and to determine its ability to differentiate the type, frequency, and severity of balance disorders. The scale (34 items) was designed by Yardley and coworkers and has been already validated in its English and Spanish versions.
98 patients with organic vertigo syndromes, 90 patients with somatoform (psychogenic) dizziness and 56 healthy controls were evaluated with the VSS and additional standardized questionnaires regarding distress (SCL-90R), quality of life (SF-36), anxiety and depression (HADS). In order to differentiate organic from somatoform dizziness all patients underwent detailed clinical neurological and vestibular neurophysiological testing.
The two identified subscales 'vertigo and related symptoms' (VER) and 'somatic anxiety and autonomic arousal' (AA) had good internal consistencies (Cronbach's alpha: VER 0.79; AA 0.89). Test-retest correlations were r = 0.75 for VER and r = 0.75 for AA. VER could discriminate well between dizziness patients and healthy controls. AA discriminated moderately between somatoform and organic dizziness. We found close relations between the AA scale and different measures of emotional distress. Correlations between VER and measures of emotional distress were weaker.
The German version of the VSS has good reliability and validity in the detection of different vertigo syndromes. Measurement of anxiety symptoms can be helpful to identify patients with somatoform dizziness.
Journal of Neurology 06/2008; 255(8):1168-75. · 3.47 Impact Factor
-
F. Leichsenring, M. Beutel,
Th. de Liz,
W. Hiller,
J. Hoyer,
E. Irle,
P. Joraschky,
H.H. König,
U. Stangier,
B. Strauß,
S. Vormfelde,
U. Willutzki,
E. Leibing
Psychotherapy & Psychosomatics. 01/2008; 78:35-41.
-
[show abstract]
[hide abstract]
ABSTRACT: Bei der Psychotherapie der Panikstörung ist die Wirksamkeit störungsbezogener verhaltenstherapeutischer Ansätze in zahlreichen randomisierten kontrollierten Studien nachgewiesen; für die Wirksamkeit einer störungsbezogenen psychodynamischen Kurzzeitpsychotherapie (panikfokussierte psychodynamische Psychotherapie, PFPP) gibt es erste empirische Belege. Die theoretische Fundierung der therapeutischen Zugänge und die daraus abgeleiteten Behandlungsprinzipien werden für die beiden Therapieverfahren dargestellt; eine aktuelle Übersicht zu empirischen Wirksamkeitsnachweisen wird gegeben: Schulenübergreifend sind Vorgehensweisen wirksam, die die Auseinandersetzung mit der Paniksymptomatik in den Mittelpunkt stellen. Die Verhaltenstherapie erreicht dies mit der Exposition gegenüber panikbezogenen Körpersensationen und -situationen; in der psychodynamischen Psychotherapie hat sich die aktive Exploration panikbezogener Kognitionen und Emotionen sowie die Deutung der für Patienten mit Panikstörungen typischen ambivalent-abhängigen, konfliktvermeidenden Übertragung bewährt. Die mit der Überwindung der habituellen Vermeidung verbundene Stärkung des Selbstwertgefühls wird als wirksamer Faktor diskutiert.
Psychotherapeut 08/2006; 51(5):334-345. · 0.36 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: This paper presents data regarding the German version of the SF-36 (Short Form 36 Questionnaire; Bullinger and Kirchberger, 1998) that were obtained from a large community based sample of the German population. Results are reported for the elderly at the age of 60 and older from the German general population (N = 690; 57% female). Presented are the internal consistencies of the scales (Cronbach's Alpha), the intercorrelations of the scales, mean values of the scales separated by sex, age group (60-64 years, 65-69 years, 70-74 years, 75-79 years, 80 years and older) and residence (Eastern and Western Germany) as well as percentile ranks for the whole sample.
Zeitschrift für Gerontologie + Geriatrie 05/2006; 39(2):109-19. · 0.61 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Im Rahmen einer bevölkerungsrepräsentativen Erhebung im Jahre 2002 wurde unter anderem der SF-36 (Short-Form-36-Questionnaire)
in der deutschsprachigen Version von Bullinger und Kirchberger (1998) zur Erfassung der gesundheitsbezogenen Lebensqualität
eingesetzt. In der vorliegenden Arbeit werden Daten für Personen aus der deutschen Allgemeinbevölkerung berichtet, die zum
Zeitpunkt der Datenerhebung 60 Jahre oder älter waren (N=690 Personen; 57% weiblich). Im Einzelnen werden die internen Konsistenzen
der Skalen (Cronbach’s Alpha), die Skalen-Interkorrelationen, Skalen-Mittelwerte differenziert nach Geschlecht, Altersgruppen
(60–64 Jahre, 65–69 Jahre, 70–74 Jahre, 75–79 Jahre, 80 Jahre und älter) und Wohnsitz (Ost-/Westdeutschland) sowie Prozentrang-Normen
für die gesamte Stichprobe dargestellt.
This paper presents data regarding the German version of the SF-36 (Short Form 36 Questionnaire; Bullinger and Kirchberger,
1998) that were obtained from a large communitybased sample of the German population. Results are reported for the elderly
at the age of 60 and older from the German general population (N=690; 57% female). Presented are the internal consistencies
of the scales (Cronbach’s Alpha), the intercorrelations of the scales, mean values of the scales separated by sex, age group
(60–64 years, 65–69 years, 70–74 years, 75–79 years, 80 years and older) and residence (Eastern and Western Germany) as well
as percentile ranks for the whole sample.
Zeitschrift für Gerontologie + Geriatrie 01/2006; 39(2):109-119. · 0.61 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Within the next parliamentary term, the German government is expected to replace the current Embryo Protection Act with a new Human Reproductive Technology Act. Before introducing new legislation, policy makers may want to survey public attitudes towards novel applications of reproductive technology. In order to assess opinions and concerns about preconception sex selection for non-medical reasons, a social survey has been conducted in Germany. As a representative sample of the German population, 1005 men and women 18 years and older were asked whether or not preconception sex selection should be made available. Of the respondents, 32% held that sex selection should be strictly prohibited, be it for medical or non-medical reasons, and 54% accepted the use of preconception sex selection for medical purposes. Only a minority of 11% approved of the use of preconception sex selection for non-medical reasons. The widespread opposition to a freely available service for non-medical sex selection is based on several claims: 87% of respondents hold that 'children are a gift and deserve to be loved regardless of any characteristics such as beauty, intelligence or sex'; 79% argue that choosing the sex of children is 'playing God'; 76% are opposed because it is seen as 'unnatural'; 49% are afraid that it is 'skewing the natural sex ratio'; and 40% consider it to be 'sexist'.
Reproductive biomedicine online 01/2005; 9(6):600-3. · 2.04 Impact Factor
-
Obstetrical and Gynecological Survey 03/2004; 59(4):253-254. · 2.51 Impact Factor
-
Psychotherapie, Psychosomatik, Medizinische Psychologie. 01/2004; 54:268-279.
-
[show abstract]
[hide abstract]
ABSTRACT: Preconception sex selection for non-medical reasons raises serious moral, legal and social issues. The main concern is based on the assumption that a freely available service for sex selection will distort the natural sex ratio and lead to a severe gender imbalance. However, for a severe gender imbalance to happen, at least two conditions have to be met. First, there must be a significant preference for children of a particular sex, and second, there must be a considerable demand for preconception sex selection. To ascertain whether or not these two conditions are met, we have conducted a survey in Germany.
As a representative sample of the German population, 1094 men and women aged 18-45 years were asked about their gender preferences and whether or not they could imagine selecting the sex of their children through flow cytometric separation of X- and Y-bearing sperm followed by intrauterine insemination.
58% of respondents stated that they do not care about the sex of their offspring. 30% wish to have a family with an equal number of boys and girls. 4% would like to have more boys than girls, 3% more girls than boys, 1% only boys and 1% only girls. For first-borns, however, there is still a preference for boys over girls. While 75.6% claimed to have no gender preference, 14.2% would like their first child to be a boy and 10.1% would like their first child to be a girl. Whereas 6% could imagine taking advantage of preconception sex selection, 92% found this to be out of the question. Even in the hypothetical case that a medication for sex selection were ever to become available, 90% stated that they would not want to use it.
Given that a majority does not seem to care about the sex of their offspring and only a minority seem to be willing to select the sex of their children, a freely available service for preconception sex selection for non-medical reasons is rather unlikely to cause a severe gender imbalance in Germany.
Human Reproduction 11/2003; 18(10):2231-4. · 4.47 Impact Factor
-
Verhaltenstherapie 01/2003; 9:5-5. · 0.59 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: To compare treatment effectiveness of psychodynamic and behavioral in-patient treatment of patients with severe obesity.
: Randomized longitudinal study of obese patients (BMI> or =35 kg/m(2)) randomly assigned to behavioral or to psychodynamic psychosomatic rehabilitation.
Ninety eight, mostly female (88%), obese patients (age 20-64 y, BMI 36-74 kg/m(2)).
Standardized self-report scales on distress (SCL-90R), eating behavior (FEV), interpersonal problems (IIP), body image (FKB-20), life satisfaction (IRES).
During the 6 weeks of in-patient treatment patients lost an average of 5.4 kg (4.3%) in the behavioral (n=46) and 6.2 kg (4.7%) in the psychodynamic setting (n=52). In both settings, a significant improvement was also found for eating behavior, well-being, body image and life satisfaction. Weight reduction was more pronounced for those with a higher weight at onset, more distress in public at admission, and a longer treatment.
Despite considerable differences in the behavioral vs psychodynamic treatment settings, both were equally effective. However, some common treatment elements were perceived differently by patients in the two settings. Analysis of the follow-up data will hopefully provide evidence as to which patients benefit more from which approach.
International Journal of Obesity 06/2001; 25 Suppl 1:S96-8. · 4.69 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Partial androgen deficiency of the aging male is associated with symptoms collectively accepted as the andropause syndrome. The underlying hormonal changes, the definition of age-dependent cofactors for changing sexuality, and the data on decreasing erectile function are the main topics of this critical analysis. Alterations in libido, ejaculation and sperm quality also have to be considered in order to define a change in male sexuality as part of the natural process of aging.
Urologia Internationalis 02/2001; 66(4):181-4. · 0.99 Impact Factor
-
W Weidner,
H Behre, M Beutel,
E Brähler,
L Hertle,
W Krause,
G Ludwig,
E Nieschlag,
A Voigt,
M P Wirth,
K Schalkhäuser,
G Popa
Urologia Internationalis 02/2001; 66(3):160-1. · 0.99 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Age-related changes in men resemble symptoms of hypogonadism. Although the average levels of testosterone decrease with age, correlations between complaints and testosterone levels are inconsistent and low in aging men. This is related to methodological limitations of studies, the high interindividual variability of testosterone in the aging male, ambiguities of normal values, and numerous determinants (e.g., health status, health behavior) on the level of testosterone. When studying the relationship between decreased testosterone, psychological and physical complaints have to take into consideration a whole array of psychosocial influences (e.g., perception, interpretation, and coping with age-related changes).
Der Urologe 10/2000; 39(5):414-7. · 0.50 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The purposes of the study were to compare treatment-related stresses of couples undergoing IVF or ICSI treatment (ejaculated, epididymal or testicular spermatozoa) and to identify sex differences and risk factors for depression. A one-year cohort of couples was retrospectively sent questionnaires on infertility and treatment-related distress and depression (Depression Scale, D-S). Two hundred and eighty-one women and 281 men (61% of those eligible) were included. As determined by analysis of the medical charts, successful couples were more likely to participate. Treatment-related distress was generally higher for women than for men. Treatment by ICSI carried additional burdens for the men: they reported a greater subjective responsibility for the infertility, impact of childlessness on daily life, treatment-related stresses (particularly for MESA/TESE) and time demands. Even when clinical differences between treatments (e.g. age, previous treatments) were controlled statistically, depression scores did not differ. Independent of the treatment, women were significantly more depressed than their age-matched female controls from the general population and their husbands. The men only reported marginally elevated depression scores compared to their controls. Meaningful characteristics were identified that could guide clinicians to give psychological support to those couples at risk for depression, e.g. an unsuccessful treatment outcome, repeated treatment cycles, a low socioeconomic status, foreign nationality, or, for women, a lack of partner support.
Andrologia 02/1999; 31(1):27-35. · 1.55 Impact Factor
-
M Beutel
[show abstract]
[hide abstract]
ABSTRACT: After a critical review of prevalence data, psychosocial determinants and psychosomatic aspects in the diagnosis and treatment of erectile dysfunction are discussed (with reference to age-related changes). Widely used laboratory assessments are responsive to psychological factors (e.g. anxiety). Inclusion of the partner in the diagnostic process may change the clinical picture and the treatment recommendations considerably. As illustrated by penile prosthetis treatment and self-injection of vasoactive substances, acceptance and success of widely used surgical and medical treatments depend largely upon the patient's expectations, and the adaptation of the couple to the procedure. Even in cases with a clear organic pathology, fluctuations in erectile functioning may be attributable to psychological influences. As recent psychotherapeutic and psychoeducational approaches underscore, erectile failure is best conceived as a final common pathway of somatic, lifestyle, psychological and partnership determinants. These should be taken into account in comprehensive diagnostic and treatment formulations if the goal of therapy is not only to produce rigid erections, but to increase sexual satisfaction.
Andrologia 02/1999; 31 Suppl 1:37-44. · 1.55 Impact Factor
